| Literature DB >> 29020013 |
Anthony Laugeray1, Ameziane Herzine1, Olivier Perche1,2, Olivier Richard1, Céline Montecot-Dubourg1, Arnaud Menuet1, Séverine Mazaud-Guittot3, Laurianne Lesné3, Bernard Jegou3, Stéphane Mortaud1.
Abstract
Accumulating evidence suggests that developmental exposure to environmental chemicals may modify the course of brain development, ultimately leading to neuropsychiatric / neurodegenerative disorders later in life. In the present study, we assessed the impact of one of the most frequently used pesticides in both residential and agricultural applications - the synthetic pyrethroid cypermethrin (CYP) - on developmental neurotoxicity (DNT). Female mice were perinatally exposed to low doses of CYP (5 and 20 mg/kg body weight) from gestation to postnatal day 15. Behavioral analyses were performed during the offspring's early life and during adulthood. Postnatal analyses revealed that perinatal exposure to CYP disturbed motor development without modifying sensory and communicative skills. We found that later in life, CYP-exposed offspring expressed maladaptive behaviors in response to highly challenging tasks and abnormal sociability. Transcriptomic analyses performed in the offspring's brain at the end of the exposure, highlighted mitochondrial dysfunction as a relevant pathomechanism underlying CYP-induced DNT. Interestingly, several genes involved in proteostasis maintenance were also shown to be dysregulated suggesting that alterations in biogenesis, folding, trafficking and degradation of proteins may significantly contribute to CYP-related DNT. From a regulatory perspective, this study highlights that behavioral and transcriptomic analyses are complementary tools providing useful direction for better DNT characterization, and as such, should be used together more systematically.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29020013 PMCID: PMC5636066 DOI: 10.1371/journal.pone.0184475
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Behavioral tests used in the two experiments.
Control and CYP-exposed offspring were exposed to both weakly and highly emotionally challenging environments. Conditions were defined as weakly challenging when the animals could escape from the stress generated by the apparatus and luminosity was low (no more than 30 lux). On the contrary, conditions were defined as highly challenging when the animals were not able to escape from the stress generated by the apparatus and luminosity was high (200 lux). The orange circles show the conditions for the CYP5-exposed offspring while the brown circles show the conditions for the CYP20-exposed offspring.
Fig 2General toxicity induced by perinatal exposure to cypermethrin.
A: Cypermethrin did not modify maternal weight gain during pre and postnatal exposure. Maternal weight gain was evaluated every two days, during the pre and postnatal period. B: Each treatment session was associated with a clinical and behavioral assessment of the mothers (see Materials and methods for details). C: On the day of delivery, sex ratio within each group and the number of pups by litter were determined. Data are mean +/- sem; Experiment 1: n = 20-21/group; Experiment 2: n = 13-14/group. ** p < 0.01 and *** p < 0.001 compared to CTL.
Fig 3Perinatal exposure to cypermethrin disturbed early postnatal development in male offspring.
A: Somatic growth and maturation endpoints revealed no significant effect of CYP. Body weight data are mean +/- sem; n = 20–21 /group in experiment 1 and n = 13–14 in experiment 2. Eyelid opening data are percent of pups with at least one eye opened. B: Neuromotor and reflex development investigate the state of motor development and its coordination, and its ability to maintain balance. CYP negatively impacted these parameters. Percentage of pups with the corresponding reflex. C: Communicative and auditory sensory functions in response to perinatal exposure to CYP. Communicative skills data are expressed in mean +/- sem; n = 20–21 /group in experiment 1 and n = 13–14 in experiment 2. Data related to auditory startle response are expressed as percent of pups having the reflex. *** p < 0.001, ** p < 0.01, *p < 0.05 and # p < 0.09.
Morphological effects observed at the end of the treatment period (PND15).
| Absolute brain weight (mg) | Absolute testis weight (mg) | Relative brain weight | Relative testis weight | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTL2 | CYP5 | CTL1 | CYP20 | CTL2 | CYP5 | CTL1 | CYP20 | CTL1 | CYP5 | CTL2 | CYP20 | CTL2 | CYP5 | CTL1 | CYP20 | |
| mean | 396.6 | 394.0 | 393.3 | 398.5 | 10.3 | 9.8 | 9.6 | 9.2 | 8.1 | 8.9 | 8.1 | 8.0 | 0.21 | 0.22 | 0.2 | 0.18 |
| sem | 4.1 | 4.3 | 3.7 | 5.1 | 0.8 | 0.3 | 0.4 | 0.8 | 0.2 | 0.3 | 0.3 | 0.2 | 0.01 | 0.01 | 0.005 | 0.02 |
Genes commonly dysregulated in the brain of CYP20 and CYP5-exposed offspring.
Fold change ≥ 1.2.
| Transcripts Cluster Id | FC ([Ctrl1] vs [Cyp20]) | Log FC ([Ctrl1] vs [Cyp20]) | Regulation ([Ctrl1] vs [Cyp20]) | FC ([Ctrl2] vs [Cyp5]) | Log FC ([Ctrl2] vs [Cyp5]) | Regulation ([Ctrl2] vs [Cyp5]) | Gene Description | Gene Symbol |
|---|---|---|---|---|---|---|---|---|
| 6888531 | -1.208 | -0.272 | -1.475 | -0.561 | olfactory receptor 1155 | Olfr1155 | ||
| 6949693 | -1.322 | -0.402 | -1.250 | -0.322 | ribosomal protein S27A | Rps27a | ||
| 6789754 | -1.322 | -0.403 | -1.297 | -0.375 | cytochrome c oxidase, subunit VIIc | cytochrome c oxidase, subunit VIIc pseudogene | Cox7c|Gm10012 | ||
| 6755306 | -1.465 | -0.551 | -1.638 | -0.712 | olfactory receptor 420 | Olfr420 | ||
| 6881087 | 1.208 | 0.273 | -1.249 | -0.321 | c-mer proto-oncogene tyrosine kinase | Mertk | ||
| 6966327 | 1.227 | 0.295 | 1.205 | 0.269 | hepcidin antimicrobial peptide | hepcidin antimicrobial peptide 2 | Hamp|Hamp2 | ||
| 6765982 | 1.286 | 0.363 | 1.224 | 0.292 | translocase of inner mitochondrial membrane 8 homolog a1 (yeast) | Timm8a1 | ||
| 6970084 | 1.362 | 0.446 | 1.273 | 0.349 | olfactory receptor 666 | Olfr666 |
Fig 4Adult CYP20-exposed offspring displayed maladaptive behavior in response to highly stressful conditions.
A: The openfield was used as a weakly challenging task. Total distance travelled in the apparatus (1–2), time spent and the mean speed in different parts of the openfield were used to assess emotional reactivity (3). B: Emotional reactivity in response to highly challenging environments was evaluated by confronting mice to a novel cage with no sawdust. Total distance travelled was monitored over the total duration of the test (1). Data were also analyzed on a minute-by minute basis (2–3). C-D: Emotional reactivity in response to highly challenging environments was evaluated in the forced swimming task and the tail suspension task. In each condition, total time spent immobile was scored over the total duration of the test (1) and on a minute-by-minute basis (2). E: Habituation to a second exposure to stressful environments was assessed by confronting mice to the forced swimming task 24h later the first trial. Performance on day 2 is depicted on (1) and (2), and habituation between day 1 and day 2 is depicted on (3) and (4). Data are mean +/- sem; n = 20–21 /group. *** p < 0.001, ** p < 0.01, *p < 0.05 and # p < 0.09.
Fig 5Adult CYP5-exposed offspring displayed maladaptive behavior in response to highly stressful conditions.
A: The elevated plus maze (EPM) was used as a weakly challenging task. Total distance travelled in the apparatus (1–2), time spent and mean speed in different parts of the EPM were used to assess emotional reactivity (3). Time spent in stretched attend postures was also measured to collect data on risk assessment (4). B: Emotional reactivity in response to weakly challenging environments was also evaluated by confronting mice to a novel slightly lighted environment during 5 min: total distance travelled was monitored over the total duration of the test (1). Data were also analyzed on a minute-by minute basis (2). C: Emotional reactivity in response to highly challenging environments was evaluated in the forced swimming task by measuring total time spent immobile over the total duration of the test (1) and on a minute-by-minute basis (2). D: Habituation to a second exposure to stressful environments was assessed by confronting mice to the EPM 24h later the first trial. Distance travelled on day 2 is depicted on (1) and (2), and habituation between day 1 and day 2 is depicted on (3) and (4). (5) and (6) show how offspring habituate between day 1 and day 2 in terms of spatial exploration of the apparatus. Data are mean +/- sem; n = 13–14 / group. *p < 0.05, ** p < 0.01, *** p < 0.001.
Fig 6Adult CYP5-exposed offspring displayed maladaptive behavior in response to social contexts.
A: In the three-chambered sociability test, CYP5-exposed offspring displayed no preference for the chamber containing the social partner (mouse 1), unlike the controls (1). When the object was replaced by a novel social partner (mouse 2) in a subsequent trial, CYP5-exposed offspring, as well as the controls, preferred interacting with the novel partner compared to the already known partner (2). * p < 0.05, ** p < 0.01, *** p < 0.001 compared to time spent in contact with wire cup containing mouse 1. B: Social skills were also assessed in more realistic conditions: in a territorial context i.e. a male—male interaction task and in a C: reproductive context i.e. male—female interaction task. In these tasks, both social and non-social behaviors were scored over the total duration of the test (1). The microstructure of social / non-social behaviors was also monitored (2). And each parameter was measured on a minute-by-minute basis (3). Data are mean +/- sem; n = 13–14 / group. *p < 0.05, ** p < 0.01, *** p < 0.001, # p < 0.09 compared to the controls.
Fig 7Putative Adverse Outcome Pathway for CYP-induced developmental neurotoxicity.
Brown boxes show molecular initiating events (MIE), key events (KEs) and adverse outcomes (AOs) related to cypermethrin exposure at the highest dose (20mg/kg; CYP20). Orange boxes show MIE, KEs and AOs related to cypermethrin exposure at the lower dose (5mg/kg; CYP5). Common mechanisms / commonly observed changes are in double-lined boxes.
Functional annotation charts for dysregulated genes in the brain of CYP20 and CYP5-exposed offspring.
| GO:0006412~translation | 1.11E-04 | RPS18, MRPL14, RPL13, RPL35, FAU, RPL37, RPS27A, GM10269, RPL29 | 2.30E-02 |
| GO:0007608~sensory perception of smell | 7.71E-04 | OLFR539, OLFR420, OLFR599, OLFR447, OLFR150, OLFR1338, OLFR1009, OLFR1155, OLFR666, OLFR32, OLFR741, OLFR10, OLFR919 | 7.78E-02 |
| GO:0003735~structural constituent of ribosome | 1.00E-06 | RPS18, GM3550, MRPL14, RPL13, RPL35, FAU, RPL37, RPS27A, GM10269, RPL29 | 1.15E-04 |
| GO:0004984~olfactory receptor activity | 1.52E-03 | OLFR539, OLFR420, OLFR599, OLFR447, OLFR150, OLFR1338, OLFR1009, OLFR1155, OLFR666, OLFR32, OLFR741, OLFR10, OLFR919 | 8.39E-02 |
| GO:0004930~G-protein coupled receptor activity | 2.66E-03 | OLFR539, OLFR420, OLFR599, TAS2R102, OLFR447, OLFR150, OLFR1009, OLFR1338, OLFR1155, OLFR666, OLFR32, VMN2R7, OLFR741, LTB4R2, OLFR919, OLFR10 | 9.71E-02 |
| GO:0022625~cytosolic large ribosomal subunit | 1.60E-05 | GM3550, RPL13, RPL35, RPL37, GM10269, RPL29 | 1.19E-03 |
| GO:0022627~cytosolic small ribosomal subunit | 4.49E-05 | HBA-A1, HBA-A2, RPS18, FAU, RPS27A | 1.66E-03 |
| GO:0005840~ribosome | 5.03E-04 | RPS18, MRPL14, RPL13, FAU, RPS27A, RPL29 | 1.23E-02 |
| GO:0015935~small ribosomal subunit | 5.28E-03 | RPS18, FAU, RPS27A | 9.33E-02 |
| GO:0045653~negative regulation of megakaryocyte differentiation | 9.88E-08 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 3.28E-05 |
| GO:0006336~DNA replication-independent nucleosome assembly | 3.39E-07 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 5.63E-05 |
| GO:0032776~DNA methylation on cytosine | 1.29E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.42E-04 |
| GO:0045815~positive regulation of gene expression, epigenetic | 1.45E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.21E-04 |
| GO:0006335~DNA replication-dependent nucleosome assembly | 1.45E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.21E-04 |
| GO:0006352~DNA-templated transcription, initiation | 2.30E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.53E-04 |
| GO:0051290~protein heterotetramerization | 5.47E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 3.02E-04 |
| GO:0006334~nucleosome assembly | 6.02E-06 | HIST1H4M, HIST1H4A, HIST1H4B, CENPA, HIST1H4F, HIST1H4C | 2.85E-04 |
| GO:0000183~chromatin silencing at rDNA | 1.11E-05 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 4.59E-04 |
| GO:0042393~histone binding | 2.19E-04 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.97E-02 |
| GO:0044822~poly(A) RNA binding | 1.27E-03 | ZFP36L2, HIST1H4M, EIF4E, RPS16, HIST1H4A, HIST1H4B, RPL15, HIST1H4F, HIST1H4C, RPS27A | 5.60E-02 |
| GO:0005179~hormone activity | 2.51E-03 | HAMP2, HAMP, PMCH, APLN | 7.34E-02 |
| GO:0019904~protein domain specific binding | 5.18E-03 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 9.01E-02 |
| GO:0031012~extracellular matrix | 1.94E-07 | HIST1H4M, RPS16, HIST1H4A, CD93, HIST1H4B, RPL9, F3, HIST1H4F, HIST1H4C | 1.69E-05 |
| GO:0000786~nucleosome | 4.00E-06 | HIST1H4M, HIST1H4A, HIST1H4B, CENPA, HIST1H4F, HIST1H4C | 1.74E-04 |
| GO:0000228~nuclear chromosome | 5.30E-06 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 1.54E-04 |
| GO:0000784~nuclear chromosome, telomeric region | 1.67E-04 | HIST1H4M, HIST1H4A, HIST1H4B, HIST1H4F, HIST1H4C | 3.62E-03 |
| GO:0070062~extracellular exosome | 1.25E-03 | HIST1H4M, FKBP5, IFITM3, RPL15, CLDN5, PPT1, DBI, EIF4E, RPS16, HIST1H4A, HIST1H4B, F3, HIST1H4F, HIST1H4C, RPS27A | 2.16E-02 |